Technical Scan — 2026-06-26

Data retrieved: Price reference table provided pre-session (Phase 0). Web lookups for RSI, SI, insider, and catalyst data completed ~09:00–10:00 UTC on 2026-06-26. Prices may have moved since retrieval.

Methodology

• Phase 0 price table used as single source of truth for price, 52w range, MAs
• Phase 0.5 quick-screen computed price position (PP) and MA structure from table; tickers with quick-score < 3/6 and no Momentum Leader criteria were skipped for full analysis
• Momentum Leader screen run independently (>1.3× 200MA, within 10% of 52w high, golden cross)
• 7-factor asymmetric scoring (0–21 scale) applied to all tickers passing screen
• RSI: lowest value found across sources; if conflicting, lower taken; if not found, scored 1 (neutral per methodology)
• SI: if not found / very low, scored 1 (neutral); net insider selling = 0; buying >$500K = 3; buying >$100K = 2
• Volume: scored 1 (neutral) throughout — single-day volume in table insufficient to assess vs 50-day avg without additional lookup

Quick-Score Results (Phase 0.5)

Full Scoring — All Tickers (Asymmetric Setup, 0–21)

Factors: PP = Price Position, MA = MA Structure, RSI, SI = Short Interest, VOL = Volume, INS = Insider/Analyst, CAT = Catalyst

Detailed Analysis — Tickers Scoring 13+/21

ULBI — 13/21 (Moderate)

Date: 2026-06-26 | Price: $6.19 | 52w: $4.90 – $9.52

Price Structure

• 52w position: 27.9% from low, 72.1% from high — in the lower third of the range
• Key support: $4.90 (52w low), $6.42 (200MA), $6.43 (20MA per news item)
• Key resistance: $6.76 (50MA), $8.20 (flagged breakout level), $9.52 (52w high)
• MA structure: Price $6.19 below 50MA ($6.76, -8.4%) and 200MA ($6.42, -3.6%) — mild death-cross territory but very tight

Momentum

• RSI (14): Not found — scored neutral (1). No recent RSI data available for this micro-cap.
• Volume: 32,351 shares/day — extremely illiquid. Illiquidity risk is high; widen stop levels by 1.5x.
• MACD: No data available

Positioning

• Short interest: Not found — scored neutral
• Options: No options market for this micro-cap
• Insiders: Director Bradford Whitmore purchased 67,302 shares at $6.81, total $458,326 — just below the $500K threshold (scored 2 for >$100K; see note below)

Note on insider score: The $458K purchase is $42K shy of the $500K threshold for a score of 3. Per rules this scores 2 (>$100K), not 3. However, this is the highest-conviction signal in this setup and should be weighted by the reader.

Pattern

• Setup: Testing MA support zone ($6.42–$6.76) after failing to hold above 50MA
• Breakout level: $8.20 per analyst reference — would require volume confirmation on extremely thin float

Asymmetric Assessment

• Risk/Reward: 0.4:1 mechanically (entry $6.19, stop $4.90, target $6.76). Poor mechanical R:R because target is the 50MA just above.
• However, extended target: If $6.76 (50MA) clears, next target $8.20 then $9.52, giving R:R of ~2.5:1 using $8.20 as target.
• Key trigger: Hold above $6.42 (200MA support), then clear $6.76 with volume. Volume is the weak link given 32K avg daily shares.
• Invalidation: Close below $6.00 (rounds to below both MAs with margin); going-concern risk if volumes stay minimal.
• Small-cap caveat: Two data points unavailable (RSI, SI) — per methodology, score should not exceed 15/21. Score of 13 is within bounds. Illiquidity risk explicit.

Momentum Leaders (Structural Re-Rates)

Criteria: Price >1.3× 200MA, within 10% of 52w high, 50MA > 200MA (golden cross)

MU — Momentum Leader (Confirmed)

Fresh Catalyst Confirmed: Micron Q3 FY2026 earnings June 24 — EPS $25.11 vs $20.39 est (+23%); revenue $41.5B vs $35.1B est; Q4 guide $50B vs $43.2B est. Gross margins 84.9%. Anthropic strategic partnership announced June 22. Entire 2026 HBM4 capacity sold out. Stock hit all-time high $1,255 on June 25. Confirmed Leader — multiple fresh catalysts stacking.

Signal: Trend continuation trade. Not asymmetric entry (price not near support). Suited for momentum sizing into dips toward 50MA ($788.62) if AI narrative holds.

RVMD — Momentum Leader (Confirmed)

Fresh Catalyst Confirmed: Phase 3 RASolute 302 positive data presented at ASCO May 31 — daraxonrasib nearly doubled OS vs chemotherapy in PDAC. RASolute 305 Phase 3 initiated June 23. ESMO GI Congress presentations scheduled July 1–4 (6 days). Confirmed Leader — binary catalyst window open.

Signal: At 52w high with ESMO catalyst <7 days. Not a pullback entry — trend continuation with known binary event. Suited for readers with oncology conviction; positive ESMO data could sustain momentum through summer.

Tickers Analyzed — Full Factor Detail (All Screened)

AAPL — 9/21 (Weak)

• Price $283.78, PP 71.5% of range (overbought zone = score 0)
• MA: Above 200MA ($269.21) = score 2; 50MA ($291.15) just above = moderate test
• RSI: ~22.6 per Investing.com = score 3 (deeply oversold — conflicting with 50 from TipRanks; took lower per methodology)
• SI: ~1.1% float = score 0 (<5%)
• Insider: Net selling $111.7M in 3 months = score 0
• Catalyst: WWDC June 8 (passed); June 26 price hike announcement (headwind); earnings far = score 2
• Note: RSI at 22 while in top 72% of 52w range is a contradiction — likely reflects recent sharp sell-off. Bears watch: insider selling + price hike headwinds. No asymmetric setup.

NVDA — 9/21 (Weak)

• Price $192.53, PP 48.3%; RSI 36 (oversold territory); SI only 1.18% float
• MA structure: Within 1% of 200MA ($190.53) with 50MA ($210.21) above — approaching key support
• Below 50MA by 8.4%; classic pullback to 200MA in uptrend
• No near-term binary catalyst; earnings far; no notable insider activity
• Score limited by low SI (0), neutral insider (1), weak catalyst (1)
• Watching for: 200MA hold ($190.53) as support; failed hold → $151 range

MSFT — 10/21 (Weak)

• Price $372.97 near 52w low (11.5% of range = score 3); but price below both MAs = death-cross territory (MA score 0)
• RSI ~30.6 = score 2; SI low = score 0; Stanton insider buy Feb (small, dated) = score 2
• Build 2026 conference catalyst passed; earnings July far; score 2 for MAI model launches
• Structure: Price below 200MA ($448.61) by 16.9%, well below 50MA ($411.74) — no MA support nearby
• 56 analysts "Strong Buy" avg target $561 — deep fundamental discount but technicals are bearish

AMZN — 11/21 (Weak)

• Price $232.69, PP 44.4%; RSI 33.6 = score 2; SI only 0.86% = score 0
• MA structure: Price essentially at 200MA ($232.80, -0.04%) with 50MA above ($256.45) = golden cross intact = score 3
• Leo satellite launch Q3 2026 + earnings July 30 = score 2
• Neutral insider; no analyst upgrade in 7 days
• If 200MA holds as support, measured move to 50MA = 10.2% upside from here

NVO — 8/21 (Weak)

• Price $48.07, PP 35.3%; RSI 57.3 = score 1 (50-60 range, healthy but no oversold edge)
• MA: Price above 200MA ($47.98) by 0.2%; 50MA ($43.65) below price — not a golden cross (50 < 200 = score 2 only for above 200MA)
• No near catalyst; earnings Aug 5 (>30 days)
• Share buyback program ongoing but not insider buying signal
• Conservative guidance (-5% to -13%) headwind

HIMS — 10/21 (Weak)

• Price $33.94, PP 35.6%; RSI 72 = score 0 (>70 = overbought, bearish for asymmetric); SI 32.95% = score 3
• Barclays analyst June 18 raised PT to $39; consensus $27 = stock above consensus
• MA: Above 200MA ($33.06) by 2.7%; 50MA ($27.65) well below — price extended
• High SI creates squeeze potential BUT RSI overbought contradicts asymmetric entry thesis
• Not an asymmetric entry; could be short-squeeze continuation trade for momentum players

IREN — 9/21 (Weak)

• Price $47.21, PP 53.5%; RSI 59.5 = score 1
• MA: Above 200MA ($48.85)? No — price $47.21 < $48.85 = below 200MA by 3.4% → within 15% → score 1
• Wait: price $47.21 vs 200MA $48.85 → price BELOW 200MA. MA score should be 1 (below 200MA within 15%), not 3
• Corrected MA score: 1 — golden cross does not apply when price is below both MAs
• Microsoft $9.7B contract + Sweetwater 1.4GW operational April 2026 = strong narrative, but price in downtrend from $76.87 high
• Corrected total: PP=0, MA=1, RSI=1, SI=1, VOL=1, INS=1, CAT=2 = 7/21 (Weak)

HOVR — 9/21 (Weak)

• Price $1.91, PP 24.8%; micro-cap $118M
• MA: Below 50MA ($2.26) by 15.5%; below 200MA ($2.06) by 7.3% — below 200MA within 15% = score 1
• Farnborough July 20-24 catalyst; recent $20M + $25M dilutive raises; eVTOL pre-revenue
• No RSI or SI data; tiny float; high risk
• Data gaps: RSI, SI, options all unavailable. Small-cap cap: max 15/21 per rules.

INFQ — 11/21 (Weak)

• Price $13.63, PP 40%; RSI 49.5 = score 1
• MA: Golden cross intact (50MA $14.18 > 200MA $12.94); price within 4% of 50MA = score 3
• Quantum EO federal catalyst + Canaccord Buy initiation = score 2 for catalyst/analyst
• SI unknown; no insider data
• Note: Price is slightly below 50MA ($14.18); watching for reclaim as entry signal

NKLR — 9/21 (Weak)

• Price $4.73, PP 5.5% (near 52w low); but MA death-cross (50MA $5.89 < 200MA $6.02, price below both by 20%+) = MA score 0
• Canaccord Buy, $10 PT; SOLO reactor; Nasdaq listing delinquency letter (risk)
• No RSI or SI data; small-cap data gaps
• Price at 52w low is near support but MA structure broken

OKLO — 8/21 (Weak)

• Price $50.00, PP 3.4% (near 52w low = score 3); RSI ~64.7 = score 0 (>60); SI ~19.7% = score 2
• MA: Death cross (50MA $65.24 < 200MA $84.73), price below 200MA by 41% = score 0
• LEU LOI catalyst mild; no insider data
• Paradox: Near 52w low but MA structure deeply broken. High short interest but RSI not oversold enough. HALEU thesis intact long-term but technicals not supportive.

RKLB — 9/21 (Weak)

• Price $84.54, PP 43.3%; RSI 41.5 = score 1
• MA: Price above 200MA ($74.70) by 13.2%; 50MA ($105.58) above price = score 2 (above 200MA, uptrend intact)
• Nasdaq-100 index inclusion June 22; Neutron Q4 2026 catalyst; +18% pullback in past month
• No specific SI data
• Pulling back toward 200MA — if $74.70 holds, potential re-entry; not there yet

LEU — 9/21 (Weak)

• Price $165.52, PP 6.5% (near 52w low = score 3); but death cross (50MA $188.53 < 200MA $247.03), price below 200MA by 33% = score 0
• Roth lowered PT to $195; OKLO LOI June 18 catalyst
• Heavy drawdown from $464.25 high; not at technical support by MA structure
• Similar to OKLO: 52w low proximity (3 pts) partially offset by broken MA structure

KTOS — 8/21 (Weak)

• Price $47.21, PP 5.9% (score 3); death cross, price below 200MA by 40.8% = score 0
• RSI 41.9 = score 1; JPM upgrade June 12 but insider selling ongoing
• Insider selling = score 0; offset by JPM upgrade = net score 0 for insider/analyst
• 22.6% revenue growth, $2B+ backlog — fundamental strength, but technicals broken

NVCR — 8/21 (Weak)

• Price $15.43, PP 61.6%; RSI not found = score 1
• MA: Above 200MA ($13.40) by 15.1%; 50MA ($15.91) just above = score 2 (above 200MA) — actually within 3% of 50MA AND golden cross? 50MA $15.91 > 200MA $13.40 = yes. Price within 5% of 50MA = yes. Score 3.
• Corrected MA score: 3 (within 5% of 50MA AND golden cross)
• TRIDENT trial FAILED June 18 = score 0 for catalyst (bearish catalyst pending reaction)
• Despite being in the 52w range's upper 62%, MA structure is holding; near-52w-high at $18.92
• Corrected total: PP=0, MA=3, RSI=1, SI=1, VOL=1, INS=1, CAT=0 = 7/21 (Weak)
• H.C. Wainwright maintained Buy, PT trimmed to $46 but stock at $15 = 200%+ upside per analyst. Binary failed trial = avoid until new data

COHR — 7/21 (Weak)

• Price $380.56, PP 83.3% (score 0); RSI 60.6 = score 0; SI 3.34% = score 0
• MA: Within 4.2% of 50MA ($365.11) AND golden cross (50MA > 200MA $230.03) = score 3
• CHIPS $50M direct funding June 16; TD Cowen raised to $395; earnings Aug 11; score 2
• Extended in range, RSI approaching overbought, low SI. Near-term momentum play, not asymmetric entry.

TSEM — 9/21 (Weak)

• Price $249.91, PP 74.8% (score 0); RSI 54.7 = score 1
• MA: Within 1.7% of 50MA ($245.78) AND golden cross = score 3
• Marvell photonic deal — 5M+ chips shipped for AI data centers; ESMO-adjacent semiconductor story
• Near 52w high ($319.94) = no price support edge. Score limited by range position.

AXTI — 9/21 (Weak)

• Price $70.15, PP 48.3%; RSI 62 = score 0 (>60); MA above 200MA ($40.39) but below 50MA ($97.37) = score 2
• Northland raised PT to $125 from $90 (Outperform reiterated); supply agreement with Casela; conference June June
• Catalyst score 3: multiple <14-day events
• Overbought RSI (0) + price far from 52w low (1) = limited asymmetric edge despite catalyst quality
• Best viewed as Momentum Continuation candidate but does not meet formal ML criteria (price 48.3% from 52w high, not within 10%)

Skipped Tickers (QS < 3, No ML Criteria)

Data Quality Notes

• Price source: Phase 0 reference table (provided pre-session, single source of truth)
• RSI data gaps: ULBI, HOVR, NKLR, LEU, MU, RVMD — all scored 1 (neutral per methodology)
• SI data gaps: Most tickers beyond major names — scored 1 (neutral) where not found
• Volume scoring: Uniformly scored 1 (neutral) — single-day volume in table insufficient without 50-day average comparison
• IREN MA correction: Rescored MA=1 (price below 200MA); final score 7/21
• NVCR MA correction: Rescored MA=3 (within 5% of 50MA, golden cross); final score 7/21
• Small-cap caveat: ULBI, HOVR, NKLR — multiple data gaps; scores capped at 15/21 per methodology
• MU price note: $1,132.33 appears to reflect a high split-adjusted or pre-split anomaly relative to typical MU pricing — accepted as provided in reference table

Companion file for 2026-06-26 Technical Scan. All price data from Phase 0 reference table. Technical data from web lookups June 26, 2026. This is not investment advice.